project id: TCGA-PRAD; case submitter id: TCGA-CH-5794; selected normal wgs: true; state: released; spectrophotometer method: UV Spec; age at index: 65; days to birth: -23924; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1941; age at diagnosis: 23924; ajcc clinical m: M0; ajcc pathologic n: N0; ajcc pathologic t: T2b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 882.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 3; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 28.0; intermediate dimension: 0.4; longest dimension: 1.1; preservation method: Unknown; shortest dimension: 0.4; sample id: d1a1ccfe-1215-4b34-94a9-c9765264f617; sample submitter id: TCGA-CH-5794-01A; portion id: 3b92677e-8847-42c7-b54c-874dd32b123f; portion submitter id: TCGA-CH-5794-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0;